Citation: Amit Kumar Roy, Priti Kumar Roy, Ellina Grigorieva. Mathematical insights on psoriasis regulation: Role of Th1 and Th2 cells[J]. Mathematical Biosciences and Engineering, 2018, 15(3): 717-738. doi: 10.3934/mbe.2018032
| [1] | Sunisa Suwannaphan . Isolation, identification and potential probiotic characterization of lactic acid bacteria from Thai traditional fermented food. AIMS Microbiology, 2021, 7(4): 431-446. doi: 10.3934/microbiol.2021026 |
| [2] | Jonathan K. Wallis, Volker Krömker, Jan-Hendrik Paduch . Biofilm formation and adhesion to bovine udder epithelium of potentially probiotic lactic acid bacteria. AIMS Microbiology, 2018, 4(2): 209-224. doi: 10.3934/microbiol.2018.2.209 |
| [3] | Thomas Bintsis . Lactic acid bacteria as starter cultures: An update in their metabolism and genetics. AIMS Microbiology, 2018, 4(4): 665-684. doi: 10.3934/microbiol.2018.4.665 |
| [4] | Hisako Nakagawa, Tadaaki Miyazaki . Beneficial effects of antioxidative lactic acid bacteria. AIMS Microbiology, 2017, 3(1): 1-7. doi: 10.3934/microbiol.2017.1.1 |
| [5] | Sukrita Punyauppa-path, Pongpat Kiatprasert, Jutaporn Sawaengkaew, Polson Mahakhan, Parichat Phumkhachorn, Pongsak Rattanachaikunsopon, Pannida Khunnamwong, Nantana Srisuk . Diversity of fermentative yeasts with probiotic potential isolated from Thai fermented food products. AIMS Microbiology, 2022, 8(4): 575-594. doi: 10.3934/microbiol.2022037 |
| [6] | Olena Livinska, Oksana Ivaschenko, Inna Garmasheva, Nadezhda Kovalenko . The screening of lactic acid bacteria with antioxidant properties. AIMS Microbiology, 2016, 2(4): 447-459. doi: 10.3934/microbiol.2016.4.447 |
| [7] | Esther Menendez, Paula Garcia-Fraile . Plant probiotic bacteria: solutions to feed the world. AIMS Microbiology, 2017, 3(3): 502-524. doi: 10.3934/microbiol.2017.3.502 |
| [8] | Garmasheva I . Isolation and characterization of lactic acid bacteria from Ukrainiantraditional dairy products. AIMS Microbiology, 2016, 2(3): 372-387. doi: 10.3934/microbiol.2016.3.372 |
| [9] | Shubhra Singh, Douglas J. H. Shyu . Perspective on utilization of Bacillus species as plant probiotics for different crops in adverse conditions. AIMS Microbiology, 2024, 10(1): 220-238. doi: 10.3934/microbiol.2024011 |
| [10] | Srirengaraj Vijayaram, Reshma Sinha, Caterina Faggio, Einar Ringø, Chi-Chung Chou . Biopolymer encapsulation for improved probiotic delivery: Advancements and challenges. AIMS Microbiology, 2024, 10(4): 986-1023. doi: 10.3934/microbiol.2024043 |
The Archaea constitute a significant portion of the Earth's microbial diversity, being dominant members of marine and soil environments [1]–[3]. With the emergence of cultivation-independent techniques, our understanding of the diversity of the Archaea is increasing, as highlighted by recent reviews [4],[5]. The diverse domain of archaea is currently divided into the superphyla of Euryarchaeota, TACK (Thaumarchaeota, Aigarchaeota, Crenarchaeota and Korarchaeota), DPANN (Diapherotrites, Parvarchaeota, Aenigmarchaeota, Nanoarchaeota, Nanohaloarchaeota, Woesearchaeota, Pacearchaeota and potentially Altiarchaea) and the recently described Asgards, consisting of Lokiarchaeota, Thorarchaeota, Odinarchaeota and Heimdallarchaeota. Members of the Asgard archaea have been described from a diverse range of habitats, including hydrothermal sediments [6]–[8], microbial mats [9], as well as a range of freshwater [10] and marine [8],[11]–[13] environments.
Thus far, a small number of studies have discussed the metabolic pathways of Asgard archaea. Some members of the Asgard archaea have been described as mixotrophic, with putatively important roles in sulfur and nitrogen cycling [11],[12]. Also identified in the genomes of Asgard archaea are a new class of rhodopsin, suggesting a phototrophic lifestyle for the Asgard [14]. Arsenic and copper resistance genes have also been identified within the genomes of Asgard archaea [9]. While a description of the metabolisms of Asgard archaea in the literature is limited, publicly available genomes are rich sources of information for reconstructing Asgard archaeal metabolic pathways.
The identification of Asgard archaea from metagenomic data has had important implications for our understanding of evolution. Historically, life has been divided into the domains of bacteria, eukarya and archaea, with the archaea and eukarya described as sister groups (referred to as the three-domain tree of life) [15]–[17]. Conversely to the three-domain topology of the tree of life, the Eocyte hypothesis proposes that the eukarya emerged from within the domain of archaea (the tree of life consisting of just the domains of archaea and bacteria), which appeared to be supported by the similarities in protein compositions between eukaryotes and a specific phylum of archaea: the Crenarchaeota [18],[19]. More recently, archaea of the TACK superphylum were found to contain proteins related to those in eukaryotes and to affiliate with eukaryotes in phylogenetic analysis, as discussed in recent reviews [20]. The Asgard archaea have increased the strength of the eukaryotic-archaeal affiliation in phylogenetic analyses [6],[8]. The Asgard archaea were also found to encode genes involved in numerous eukaryotic characteristic systems, many of which were formerly considered to be eukaryotic-specific [6],[8].
Here we review the latest discoveries in relation to the Asgard superphylum, including the controversies surrounding their discovery. Specifically, this review will discuss how cultivation-independent sequencing data has informed our understanding of the ecology, lifestyle, and evolutionary implications of the Asgard superphylum.
Asgard archaea were formerly grouped as Marine Benthic Group B (MBG-B) [21], Ancient Archaeal Group (AAG) [22], Deep-Sea Archaeal Group (DSAG) [23],[24], and Marine Hydrothermal Vent Group (MHVG) [22] archaea. Lokiarchaeota, the first phylum of Asgard archaea to be described, was initially identified from deep marine sediments of a hydrothermally active site [6]. Later, the Asgard archaeal phyla of Thorarchaeota [11], Odinarchaetoa, and Heimdallarchaetoa [8] were characterized by metagenomic profiling of a range of sedimentary environments across the globe. The habitats of which Asgard archaea have been metagenomically characterized from are largely anaerobic, including deep marine sediments, terrestrial soils and pelagic water (Figure 1).
Lokiarchaeota appear more abundant in currently characterized microbiomes, whereas Thorarchaeota, Heimdallarchaeota, and Odinarchaetoa appear at relatively lower abundances [8]. Environmental information acquired from NCBI and MG-RAST metagenomic databases (Table S1) associate Odinarchaeota with geothermal environments [8]. Heimdallarchaeota and Lokiarchaeota are primarily found in marine sediments whereas Thorarchaeota appears to occur in a diverse range of microbiomes, notably, marine, lake, and estuarine sediments (Table S1) [8]. Overall, Asgard archaea are more abundant in methane-rich or hydrothermal environments, rather than terrestrial soil or freshwater environments. The analysis of high-throughput 16S rRNA data may provide further insights into the distribution of Asgard archaea. Current and future research should aim to distinguish Asgard archaeal 16S rRNA operational taxonomic units (OTUs) to uncover more information regarding their habitats.
Asgard archaea may play key roles in the function of ecosystems through microbe-microbe interactions. Correlations between microorganisms whether positive or negative can provide insight into interactions such as signaling systems, metabolite exchange, and other biotic or physiochemical activities [25]. Deducing the microbial relationships from correlation network studies can help determine the drivers behind Asgard archaea function and how habitat niches form and operate [26]. A recent study observed a strong positive correlation between Lokiarchaeota and the bacterial division TA06 within the microbial mats of Salar de Llamara, Chile; a warm, saline and shallow marine environment [27]. The abundance of Lokiarchaeota and TA06 was relatively low in the deeper sections of the microbial mats yet they exhibited the only strong positive correlation of Asgard archaea in this system [27]. Both TA06 and Lokiarchaeota are known to live in anoxic conditions and therefore this correlation may pose an interesting bacterial-archaeal interaction that requires further study. Co-occurrence analysis of Asgard groupings with other microbes may offer insights into potential mutualistic interactions. The correlations and specific interactions observed so far are unexplained, offering an opportunity to bridge the gap in knowledge. Among other microorganisms, Asgard archaea are mostly exposed to anoxic conditions as well as a range of elements such as organic and inorganic carbon sources, sulfur, and nitrogen [28]. These conditions provide the substrates for their metabolism and multiple studies have begun to uncover their metabolic capabilities, reviewed in the following section.
Glycolysis appears to be ubiquitous among Asgard archaea, with all the genomes only lacking hexokinase (Figure 2). All four phlya have the genetic capacity to degrade peptides, while all but Odinarchaeota encodes for a complete butanoyl-CoA oxidation pathway. Since all Asgard archaea are able to obtain carbon sources through degrading carbohydrate and peptides, this indicates a heterotrophic lifestyle [11],[12],[29] (Figures 2 and 3). A summary of putative metabolic genes identified is given in Table S2.
Wood-Ljungdahl (WL) pathways were also identified in Asgard archaea [9],[12],[29]. There are two types of WL pathway, one using tetrahydrofolate (THF) as the C1 carrier while the other one uses tetrahydromethanopterin (THMPT). Generally, bacteria encode for the THF-WL pathway while archaea harbor the THMPT-WL pathway [30],[31]. Studies have identified that Thorarchaeota from sulfate-methane transition zones, hypersaline microbial mats, and mangroves harbor a complete set of genes in the THMPT-WL pathway, suggesting the ability to fix carbon dioxide through autotrophic acetogenesis [9],[11],[12]. These Thorarchaeota genomes also encode for genes associated with the THF-WL pathway, indicating they can use both THMPT and THF as a C1 carrier [9],[12].
On the other hand, Lokiarchaeota was shown to be a hydrogen-dependent, anaerobic autotrophic archaeon, harboring a complete THMPT-WL pathway, which would facilitate the fixing of carbon dioxide [29]. In the present study 23 Asgard archaeal genomes were downloaded from public repositories and annotated against the KEGG database [32]. Despite being previously unreported, we found that both Heimdallarchaeota and Odinarchaeota also encode a complete THMPT-WL pathway, with Heimdallarcheota also encoding for a complete THF-WL pathway (Figure 2). Given the fact that Asgard archaea are capable of metabolizing autotrophically and heterotrophically, this suggests that this superphylum lives a mixotrophic lifestyle, although such a lifestyle was only reported in Thorarchaeota [12]. To summarize, all four Asgard archaea phyla putatively utilize THMPT as C1 carriers while both Thorarchaeota and Heimdallarchaeota can also use THF as C1 carriers (Figure 2) [33]. As the Wood-Ljungdahl pathway is the only complete carbon fixation pathway identified in the available data, it is likely that Wood-Ljungdahl pathway is the preferred carbon fixation pathway among the Asgard archaea.
Other partially complete carbon fixation pathways such as the 4-hydroxybutyrate cycle were also found in Thorarchaeota and Lokiarchaeota, with the genomes encoding for the key genes 4-hydroxybutytyl-CoA dehydratase and enoyl-CoA hydratase. Although only previously reported in Asgard archaea genomes from hypersaline microbial mats [9], the aforementioned genes were also identified in Asgard genomes from marine sediments, estuary sediments and mangroves [8],[11],[12]. Interestingly, the gene responsible for reverse TCA (rTCA) cycle was found in two Lokiarchaeota genomes from marine sediment and hypothermal vent sediment respectively, which has not been previously reported.
Thorarchaeota, Lokiarchaeota, and Heimdallarchaeota were found to harbor ribulose bisphosphate carboxylase (RuBisCo), the main gene in the carbon-fixing Calvin-Benson-Bassham phototrophic pathway [9],[11],[12]. However, phylogenetic analysis revealed that the Asgard archaeal RuBisCo are not photosynthetic, but rather affiliated with type IV or archaeal type III. These forms of RuBisCo are not involved in the Calvin-Benson-Bassham (CBB) cycle, but rather in salvaging and assimilating nucleosides [34],[35]. This infers that Asgard archaea is capable of assimilating salvaged nucleotides into central carbohydrate pathways.
Recently, a type 1 proton-pumping rhodopsin was identified in Heimdallarchaeota and Thorarchaeota, which was coined as a novel pigment—heliorhodopsin [14]. This suggests that in the early Earth, heliorhodopsin-bearing Asgard archaea were likely located at the top of light-exposed habitats. This highlights the potential ability of Asgard archaea to sense and capture sunlight.
Evidence of nitrogen cycling potential was found in Heimdallarchaeota genomes, possessing both nitrate reductase and nitrite reductase (NO forming), suggesting its involvement in dissimilatory nitrate reduction (DNRA) and denitrification (Figure 2). On the other hand, nitrogenase was only reported in Thorarchaeota from hypersaline microbial mats and mangroves [9],[12], inferring their role in assimilating atmospheric nitrogen into ammonia. Nitrite reductase (NADH) was also identified in all Asgard archaeal phyla except Odinarchaeota, where it was suggested that nitrite could be the nitrogen source among Asgard archaea other than peptides [9],[12]. This also suggests that Asgard archaea play a role in nitrogen transformation.
All Asgard archaea encode for both sulfate adenylyltransferase and phosphoadenosine phosphosulfate reductase, indicating their putative ability in assimilatory sulfate reduction and sulfate activation (Figure 2). There were no studies reporting dissimilatory sulfate reduction and sulfur oxidation (SOX) systems. However, evidence of thiosulfate reductase and sulfhydrogenase were identified in Thorarchaeota in estuary sediments, while thiosulfate sulfurtransferase was identified in Thor-, Heimdall- and Odinarchaeota [8]. This suggests that these organisms may be involved in the transformation (particularly reduction) of intermediate sulfur compounds [11].
All four Asgard archaeal phyla have the genomic capacity to reduce As(V) with arsenate reductase and efflux arsenite through arsenite transporter (Figure 2). High arsenic concentrations were detected in mangrove sediments, however low levels were detected in hypersaline microbial mats [9],[36]. Arsenic transformation and resistance appear to be ubiquitous in various environments among Asgard archaea irrespective of arsenic concentrations (Figure 3), suggesting arsenic metabolisms as a relic of an ancient microbial trait [37],[38]. Similarly for copper resistance, despite only Shark Bay hypersaline microbial mats having been reported with relatively high copper concentrations [9], most of the genomes harbor a copper efflux system, inferring this as a potential universal trait among Asgard archaea in different microbiomes.
As most Asgard archaeal genomes and 16S rDNA to date were extracted from anoxic environments [8],[9],[11],[12],[27],[30], and most Asgard archaea lack a complete tricarboxylic acid cycle (TCA) cycle and are capable of anaerobic metabolisms such as WL-pathway, they were thought to be obligately anaerobic.
The origin of the eukaryotic cell has remained one of the most contentious debates in evolutionary biology. Two hypothesises have emerged to describe the evolution of the eukaryotic cell, depicted in Figure 4. Firstly, the Woese model of archaea and eukarya diverging from a common ancestor to the exclusion of bacteria [16], and secondly the Eocyte hypothesis, in which eukarya emerged from within the archaea [18]. The recent reporting of the Asgard superphylum has given support to the Eocyte hypothesis [6],[8], although this has added controversy within the context of the current Woese tree of life dogma, with alternative analyses of Asgard archaea supporting Woese models [39].
The identification of the Asgard superphylum from metagenomic data has been taken as evidence of the Eocyte hypothesis. In the original phylogenetic analyses of an Asgard archaea, Lokiarchaeota was found to represent a monophyletic clade of the TACK superphylum [6]. Inclusion of eukarya in such phylogenies positioned eukarya within the Asgard archaea, hinting at the close relationship between the two groups. At the time, it was suggested that Lokiarchaeota represented the closest archaeal relatives of eukaryotes [6]. The later identified phyla of Thorarchaeota [11], Heimdallarchaeota and Odinarchaeota [8], were found to form a monophyletic group with Lokiarchaeota, proposed as the Asgard superphylum, which represented a sister group to the TACK superphylum [8]. Phylogenetic analyses of the Asgard superphylum using ribosomal RNA genes, universally conserved marker genes and ribosomal proteins placed eukarya within the Asgard archaea, with Heimdallarchaeota suggested as the closest archaeal relatives of the eukarya (Figure 5A) [8],[12]. Although Asgard archaea affiliate strongly with eukarya in such phylogenetic analyses, the exact evolutionary relationship between the two groups has yet to be determined.
The placement of Asgard archaea as the closest archaeal relatives of eukaryotes has been criticized by some, which alternatively proposes the Asgard superphylum to be a sister group of the Euryarchaeota [39]. Da Cunha and colleagues [39] suggest that the placement of the eukaryotes within the Asgard superphylum or as a sister group to Asgard archaea in phylogenetic analyses is potentially the result of phylogenetic artefacts and/or contamination or homologous recombination of Asgard genomes with eukaryotic sequences. However direct evidence of contamination or recombination has yet to be shown, and thus further work is needed to definitively prove this claim. The accuracy of claims of contamination and/or homologous recombination have themselves been contested, with some claiming misinterpretation of the original findings and not accounting for the other previously published Asgard archaea (including Thor-, Heimdall- and Odinarchaeota) which also provide evidence of a strong eukaryotic affiliation [40]. As it is unlikely that contamination and/or homologous recombination with eukaryotic sequences occurred in the same manner across the Asgard archaea, genomes of which were assembled from a variety of sources using a variety of methodologies [6],[8],[12], it is unlikely that the eukaryotic-Asgard affiliation is the result of contamination with eukaryotic sequences.
Da Cunha and co-workers [39] performed their own phylogeny on RNA polymerases in the original Lokiarchaeota genome, developing alternative phylogenetic trees indicating Lokiarchaetoa is a sister group to the Euryarchaeota, supporting a three-domain tree of life (Figure 5B) [39]. However, the phylogenetic trees produced have been criticized for failing to account for phylogenetic artefacts and lack the statistical significance to draw strong conclusions about the placement of Asgard archaea in the tree of life [40].
Genomic exploration found that the genome of Lokiarchaeota encoded numerous proteins that were previously considered to be eukaryotic specific [6]. Lokiarchaeota was found to possess eukaryotic signature proteins (ESP) involved in a broad range of eukaryotic process, including membrane-related processes and cell shape dynamics [6]. With the identification of Thorarchaeota, Odinarchaeota, and Heimdallarchaeota, the repertoire of ESP in Asgard genomes was expanded, suggesting that ESP are widespread across the Asgard superphylum. Thus far, Asgard archaea have been found to encode a diverse range of ESP, including proteins involved in eukaryotic membrane trafficking machinery, eukaryotic-like structural and cytoskeleton proteins, proteins involved the ubiquitination modification system, and eukaryotic-like ribosomal proteins [6],[8],[41]. The presence of eukaryotic-like systems in the Asgard superphylum suggests that eukaryotes inherited simple variations of eukaryotic cellular machinery from an archaeal ancestor. However, many of the eukaryotic systems putatively encoded in Asgard archaea are incomplete or are yet to be functionally characterized. As they possess yet unknown functions in archaea, it is difficult to infer the mechanism by which eukaryotic systems developed within the archaea.
While the majority of the ESP encoded in Asgard archaeal genomes are yet to be functionally annotated, recent research has begun to employ cultivation independent techniques to better understand how eukaryotic-like systems act in archaea. One of the key characteristics of eukaryotic cells is the dynamic cytoskeleton. Profilins are a known class of regulators of eukaryotic cytoskeleton dynamics [42]. It has been recently reported that Asgard archaea encode eukaryotic-like multifunctional profilins [6],[8],[43], unlike the singular function profilins of prokaryotes [44]. Although researchers have been unable to demonstrate their interaction with Asgard actins, Asgard profilins have been shown to interact with eukaryotic actin [43], despite the billions of years of evolution that have occurred since the divergence of the archaeal-eukaryotic common ancestor [45],[46]. The reporting of Asgard profilin which is both structurally and functionally related to its eukaryotic counterpart suggests that Asgard archaea have the potential for dynamic actin regulation [43], which could be explained by a common archaeal ancestor of eukaryotes and Asgard archaea.
Similarly, the formerly eukaryotic-specific ubiquitin modification system, which has been reported in a variety of archaea, was found to be functional in the uncultured archaeon Candidatus “Caldiarchaeum subterraneum” [47],[48]. Although not verified in Asgard archaea which also putatively encode components of a ubiquitin modification pathway [6],[8], such research indicates that the ubiquitin modification pathway may have eukaryotic-like functions in archaea. The presence of a functional, eukaryotic-like ubiquitination system in archaea suggests that eukaryotes inherited the ubiquitin modification system from an archaeal ancestor.
In addition to the abundance of ESP in Asgard genomes, some have noted the similarity between eukaryotic and Asgard archaeal RNA structures. The mechanisms by which the three domains of life insert selenocysteine (SEC) during translation are vastly different between the bacteria, the archaea, and the eukarya [49]–[51]. The selenocysteine insertion sequence (SECIS) of Lokiarchaeaota possesses similarity to the RNA structures of eukaryotic SECIS, as well as bearing similarity to the SECISs of archaeal selenoproteins [52]. Thus, it has been proposed that Lokiarchaeota encode an intermediate archaeal-eukaryotic selenocysteine insertion system, suggesting the eukaryotic SECIS has archaeal evolutionary origins [52].
This review has highlighted the state-of-the-art in relation to Asgard archaeal research, with a focus on key discoveries that have underpinned our understanding of the lifestyle, ecology, and evolution of this unique branch of life. Some of the discoveries are not without their controversies, however this leads to a healthy debate and more focused research directions that will benefit this field. As metagenomic, metatranscriptomic, and metaproteomic datasets from numerous environmental microbiomes continue to be resolved at rapid rates, it is likely novel aspects of this enigmatic group are waiting to be elucidated.
| [1] | [ F. O. Nestle,P. D. Meglio,J. Z. Qin,B. J. Meglio, Skin immune sentinels in health and disease, Nature Reviews Immunology, 9 (2009): 679-691. |
| [2] | [ World Health Organization, Global report on Psoriasis, WHO Library Cataloguing-in-Publication Data, 2016. |
| [3] | [ M. L. Ford,B. H. Koehn,M. E. Wagener,W. Jiang,S. Gangappa,T. C. Pearson,C. P. Larsen, Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation, Journal of Experimental Medicine, 204 (2007): 299-309. |
| [4] | [ J. Song,F. T. Lei,X. Xiong,R. Haque, Intracellular signals of T cell costimulation, Cellular & Molecular Immunology, 5 (2008): 239-247. |
| [5] | [ T. J. Kindt, R. A. Goldsby, B. A. Osborne and J. Kuby, Kuby Immunology, Macmillan, 2007. |
| [6] | [ A. Yates,C. Bergmann,J. L. Van Hemmen,J. Stark,R. Callard, Cytokine-modulated regulation of helper T cell populations, Journal of Theoretical Biology, 206 (2000): 539-560. |
| [7] | [ P. Bousso, T-cell activation by dendritic cells in the lymph node: Lessons from the movies, Nature Reviews Immunology, 8 (2008): 675-684. |
| [8] | [ Y. Cai,C. Fleming,J. Yan, New insights of T cells in the pathogenesis of psoriasis, Cellular and Molecular Immunology, 9 (2012): 302-309. |
| [9] | [ H. Valdimarsson,B. S. Bake,I. Jónsdótdr,L. Fry, Psoriasis: A disease of abnormal keratinocyte proliferation induced by T lymphocytes, Immunology Today, 7 (1986): 256-259. |
| [10] | [ J. T. Chang,V. R. Palanivel,I. Kinjyo,F. Schambach,A. M. Intlekofer,A. Banerjee,S. A. Longworth,K. E. Vinup,P. Mrass,J. Oliaro,N. Killeen, Asymmetric T lymphocyte division in the initiation of adaptive immune responses, Science, 315 (2007): 1687-1691. |
| [11] | [ J. Rengarajan,S. J. Szabo,L. H. Glimcher, Transcriptional regulation of Th1/Th2 polarization, Immunology Today, 21 (2000): 479-483. |
| [12] | [ J. H. Mao,E. F. Saunier,J. P. de Koning,M. M. McKinnon,M. N. Higgins,K. Nicklas,H. T. Yang,A. Balmain,R. J. Akhurst, Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility, Proceedings of the National Academy of Sciences, 103 (2006): 8125-8130. |
| [13] | [ A. Balato, F. Ayala, M. Schiattarella, M. Megna, N. Balato and S. Lembo, Pathogenesis of Psoriasis: the role of pro-inflammatory cytokines produced by keratinocytes, J. Soung (Ed. ), Pathogenesis of Psoriasis: The Role of Pro-Inflammatory Cytokines Produced by Keratinocytes, InTech, Shanghai, (2012), p372. |
| [14] | [ J. Baliwag,D. H. Barnes,A. Johnston, Cytokines in Psoriasis, Cytokine, 73 (2015): 342-350. |
| [15] | [ Y. Kogan,Z. Agur,M. Elishmereni, A mathematical model for the immunotherapeutic control of the Th1/Th2 imbalance in melanoma, Discr Cont Dyn Syst Ser B, 18 (2013): 1017-1030. |
| [16] | [ A. T. Pietrzak,A. Zalewska,G. Chodorowska,D. Krasowska,A. Michalak-Stoma,P. Nockowski,P. Osemlak,T. Paszkowski,J. M. Roliński, Cytokines and anticytokines in Psoriasis, Clinica Chimica Acta, 394 (2008): 7-21. |
| [17] | [ K. Ghoreschi,P. Thomas,S. Breit,M. Dugas,R. Mailhammer,W. van Eden,R. van der Zee,T. Biedermann,J. Prinz,M. Mack,U. Mrowietz, Interleukin-4 therapy of Psoriasis induces Th2 responses and improves human autoimmune disease, Nature Medicine, 9 (2002): 40-46. |
| [18] | [ K. Asadullah,W. Sterry,U. Trefzer, Cytokines: Interleukin and interferon therapy in dermatology, Clinical and Experimental Dermatology, 27 (2002): 578-584. |
| [19] | [ A. D'andrea,M. Aste-Amezaga,N. M. Valiante,X. Ma,M. Kubin,G. Trinchieri, Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells, The Journal of Experimental Medicine, 178 (1993): 1041-1048. |
| [20] | [ S. Jain,I. R. Kaur,S. Das,S. N. Bhattacharya,A. Singh, T helper 1 to T helper 2 shift in cytokine expression: An autoregulatory process in superantigen-associated Psoriasis progression?, Journal of Medical Microbiology, 58 (2009): 180-184. |
| [21] | [ A. Coondoo, The role of cytokines in the pathomechanism of cutaneous disorders, Indian Journal of Dermatology, 57 (2012): 90-96. |
| [22] | [ G. D. Weinstein,J. L. McCullough,P. A. Ross, Cell kinetic basis for pathophysiology of Psoriasis, Journal of Investigative Dermatology, 85 (1985): 579-583. |
| [23] | [ B. S. Baker,A. F. Swain,L. Fry,H. Valdimarsson, Epidermal T lymphocytes and HLA-DR expression in Psoriasis, British Journal of Dermatology, 110 (1984): 555-564. |
| [24] | [ P. Nockowski,J. C. Szepietowski,M. Ziarkiewicz,E. Baran, Serum concentrations of transforming growth factor beta 1 in patients with Psoriasis vulgaris, Acta Dermatovenerologica Croatica: ADC, 12 (2003): 2-6. |
| [25] | [ M. A. Lowes,A. M. Bowcock,J. G. Krueger, Pathogenesis and therapy of Psoriasis, Nature, 445 (2007): 866-873. |
| [26] | [ K. Asadullah,W. Sterry,H. D. Volk, Interleukin-10 therapy--review of a new approach, Pharmacological Reviews, 55 (2003): 241-269. |
| [27] | [ J. Tzu,A. J. Mamelak,D. N. Sauder, Current advancements in the treatment of Psoriasis: Immunobiologic agents, Clinical and Applied Immunology Reviews, 6 (2006): 99-130. |
| [28] | [ K. Reich,M. Bruck,A. Grafe,C. Vente,C. Neumann,C. Garbe, Treatment of Psoriasis with interleukin-10, J Invest Dermatol, 111 (1998): 1235-1236. |
| [29] | [ K. Asadullah,W. D. Döcke,M. Ebeling,M. Friedrich,G. Belbe,H. Audring,H. D. Volk,W. Sterry, Interleukin 10 treatment of Psoriasis: Clinical results of a phase 2 trial, Archives of Dermatology, 135 (1999): 187-192. |
| [30] | [ K. Reich,V. Blaschke,C. Maurer,U. Lippert,C. Neumann,C. Garbe,P. Middel,G. Westphal, Response of Psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation, Journal of Investigative Dermatology, 116 (2001): 319-329. |
| [31] | [ M. Friedrich,W. D. Döcke,A. Klein,S. Philipp,H. D. Volk,W. Sterry,K. Asadullah, Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis, Journal of Investigative Dermatology, 118 (2002): 672-677. |
| [32] | [ I. B. McInnes,G. G. Illei,C. L. Danning,C. H. Yarboro,M. Crane,T. Kuroiwa,R. Schlimgen,E. Lee,B. Foster,D. Flemming,C. Prussin, IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis, The Journal of Immunology, 167 (2001): 4075-4082. |
| [33] | [ P. K. Roy,A. Datta, Negative Feedback Control may Regulate Cytokines Effect during Growth of Keratinocytes in the Chronic Plaque of Psoriasis: A Mathematical Study, International Journal of Applied Mathematics, 25 (2012): 233-254. |
| [34] | [ P. K. Roy and A. Datta, Impact of perfect drug adherence on immunopathogenic mechanism for dynamical system of Psoriasis, Biomath, 2 (2013), 1212101, 6 pp. |
| [35] | [ A. Datta,P. K. Roy, T-cell proliferation on immunopathogenic mechanism of Psoriasis: A control based theoretical approach, Control and Cybernetics, 42 (2013): 365-386. |
| [36] | [ H. Zhang, W. Hou, L. Henrot, S. Schnebert, M. Dumas, C. Heuséle and J. Yang, Modelling epidermis homoeostasis and Psoriasis pathogenesis, Journal of The Royal Society Interface, 12 (2015), Article ID : 20141071. |
| [37] | [ H. B. Oza,R. Pandey,D. Roper,Y. Al-Nuaimi,S. K. Spurgeon,M. Goodfellow, Modelling and finite time stability analysis of Psoriasis pathogenesis, International Journal of Control, 90 (2017): 1664-1677. |
| [38] | [ J. C. Maxwell, On governors, Proceedings of the Royal Society of London, 16 (1867): 270-283. |
| [39] | [ E. J. Routh, A treatise on the stability of a given state of motion: Particularly steady motion, Macmillan and Company, 1877. |
| [40] | [ A. Hurwitz, On the conditions under which an equation has only roots with negative real parts, Selected papers on mathematical trends in control theory, 65 (1964): 273-284. |
| [41] | [ E. V. Grigorieva,E. N. Khailov,N. V. Bondarenko,A. Korobeinikov, Modeling and optimal control for antiviral treatment, Special issue on Analytic Modeling in Biology and Medicine of Journal of Biological Systems, 22 (2014): 199-217. |
| [42] | [ E. V. Grigorieva, E. N. Khailov and A. Korobeinikov, Optimal control problem in HIVtreatment Discrete and Continuous Dynamical Systems, supplement volume, (2011), 311-322. |
| [43] | [ W. H. Fleming and R. W. Rishel, Deterministic and Stochastic Optimal Control, Springer-Verlag, Berlin-New York, 1975. |
| [44] | [ W. H. Fleming, R. W. Rishel, G. I. Marchuk, A. V. Balakrishnan, A. A. Borovkov, V. L. Makarov, A. M. Rubinov, R. S. Liptser, A. N. Shiryayev, N. N. Krassovsky and A. N. Subbotin, Applications of Mathematics, Deterministic and Stochastic Optimal Control, 1975. |
| [45] | [ A. N. Chatterjee,P. K. Roy, Anti-viral drug treatment along with immune activator IL-2: A control-based mathematical approach for HIV infection, International Journal of Control, 85 (2012): 220-237. |
| [46] | [ A. A. Lashari,G. Zaman, Optimal control of a vector borne disease with horizontal transmission, Nonlinear Analysis: Real World Applications, 13 (2012): 203-212. |
| [47] | [ D. Kirschner,S. Lenhart,S. Serbin, Optimal control of the chemotherapy of HIV, Journal of Mathematical Biology, 35 (1997): 775-792. |
| [48] | [ G. Birkhoff and G. C. Rota, Ordinary Differential Equations, fourth ed., John Wiley & Sons, New York, 1989. |
| [49] | [ D. L. Lukes, Differential Equations: Classical to Controlled, Mathematics in Science and Engineering, Academic Press, New York, 1982. |
| [50] | [ S. Lenhart and J. T. Workman, Optimal Control Applied to Biological Models, Mathematical and Computational Biology Series, 2007, Chapman & Hall, Crc Press, London, UK. |
| [51] | [ V. Lakshmikantham, D. D. Bainov and P. S. Simeonov, Theory of Impulsive Differential Equations, World scientific, 1989. |
| [52] | [ D. Biswas,D. K. Kesh,A. Datta,A. N. Chatterjee,P. K. Roy, A mathematical approach to control cutaneous leishmaniasis through insecticide spraying, Sop Transactions on Applied Mathematics, 1 (2014): 44-54. |
| [53] | [ D. D. Bainov and P. S. Simeonov, Impulsive Differential Equations: Asymptotic Properties of the Solutions, World Scientific, 1995. |
| [54] | [ P. K. Roy,A. Datta, Impact of cytokine release in psoriasis: A control based mathematical approach, Journal of Nonlinear Evolution Equations and Applications, null (2013): 23-42. |
| [55] | [ P. K. Roy,A. Datta,S. Rana, The Fractional-order differential equation model of psoriatic pathogenesis: A mathematical study, Journal of Systems Science and Complexity, 15 (2013): 35-46. |
| [56] | [ X. Cao,A. Datta,F. Al Basir,P. K. Roy, Fractional-order model of the disease Psoriasis: A control based mathematical approach, Journal of Systems Science and Complexity, 29 (2016): 1565-1584. |
| [57] | [ G. Magombedze, S. Eda and V. V. Ganusov, Competition for antigen between Th1 and Th2 responses determines the timing of the immune response switch during Mycobaterium avium subspecies paratuberulosis infection in ruminants, PLoS Comput Biol, 10 (2014), e1003414. |
| [58] | [ R. Fernandez-Botran,V. M. Sanders,T. R. Mosmann,E. S. Vitetta, Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells, Journal of Experimental Medicine, 168 (1988): 543-558. |
| [59] | [ Y. Kim,S. Lee,Y. S. Kim,S. Lawler,Y. S. Gho,Y. K. Kim,H. J. Hwang, Regulation of Th1/Th2 cells in asthma development: A mathematical model, Math Biosci Eng, 10 (2013): 1095-1133. |
| [60] | [ P. K. Denman,D. S. McElwain,D. G. Harkin,Z. Upton, Mathematical modelling of aerosolised skin grafts incorporating keratinocyte clonal subtypes, Bulletin of mathematical biology, 69 (2007): 157-179. |
| [61] | [ G. D. Weinstein,J. L. McCullough,P. Ross, Cell proliferation in normal epidermis, Journal of Investigative Dermatology, 82 (1984): 623-628. |
| [62] | [ A. A. Al-Robaee,A. A. Al-Zolibani,H. A. Al-Shobili,A. Kazamel,A. Settin, IL-10 implications in psoriasis, International Journal of Health Sciences, 2 (2008): 53-58. |
| 1. | Yongqiang Zhao, Yanbin Tang, Approximation of solutions to integro-differential time fractional wave equations in space, 2023, 18, 1556-1801, 1024, 10.3934/nhm.2023045 | |
| 2. | Junlong Chen, Yanbin Tang, Homogenization of nonlinear nonlocal diffusion equation with periodic and stationary structure, 2023, 18, 1556-1801, 1118, 10.3934/nhm.2023049 | |
| 3. | Yongqiang Zhao, Yanbin Tang, Critical behavior of a semilinear time fractional diffusion equation with forcing term depending on time and space, 2024, 178, 09600779, 114309, 10.1016/j.chaos.2023.114309 | |
| 4. | Caihong Gu, Yanbin Tang, Well-posedness of Cauchy problem of fractional drift diffusion system in non-critical spaces with power-law nonlinearity, 2024, 13, 2191-950X, 10.1515/anona-2024-0023 | |
| 5. | Yongqiang Zhao, Yanbin Tang, Approximation of solutions to integro-differential time fractional order parabolic equations in -spaces, 2023, 2023, 1029-242X, 10.1186/s13660-023-03057-2 |
Figures(7) / Tables(1)
Amit Kumar Roy, Priti Kumar Roy, Ellina Grigorieva. Mathematical insights on psoriasis regulation: Role of Th1 and Th2 cells[J]. Mathematical Biosciences and Engineering, 2018, 15(3): 717-738. doi: 10.3934/mbe.2018032
DownLoad:
